Molecular Markers for Thyroid Cancer - Masha Livhits, MD & Michael Yeh, MD - UCLAMDChat

Explore the latest advancements in thyroid cancer diagnosis with UCLA endocrine surgeons Dr. Michael Yeh and Dr. Masha Livhits in this informative 43-minute webinar. Gain insights into molecular approaches for diagnosing thyroid cancer, focusing on molecular markers as valuable tools for assessing indeterminate thyroid nodules. Learn about risk factors, over-diagnosis concerns, and the principles of molecular testing. Discover how these innovative techniques can help avoid unnecessary surgeries, and understand UCLA's current practices and study results in this field. Delve into patient stories, prognosis considerations, and participate in a Q&A session to enhance your understanding of this crucial topic in endocrine surgery.

Introduction
Overview
Risk Factors
Over Diagnosis
Indeterminate biopsy
Patient story
What is molecular testing
Principles of testing
First molecular test
First molecular test examples
Second molecular test
Examples
How molecular testing avoids unnecessary surgery
UCLA experience with molecular testing
Current practice at UCLA
Study results
Prognosis
Avoid surgery
Summary
Questions